DZ2509A1 - Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant. - Google Patents

Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.

Info

Publication number
DZ2509A1
DZ2509A1 DZ980119A DZ980119A DZ2509A1 DZ 2509 A1 DZ2509 A1 DZ 2509A1 DZ 980119 A DZ980119 A DZ 980119A DZ 980119 A DZ980119 A DZ 980119A DZ 2509 A1 DZ2509 A1 DZ 2509A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
peptide analogs
analogs
peptide
Prior art date
Application number
DZ980119A
Other languages
English (en)
Inventor
Remi Delansome
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DZ2509A1 publication Critical patent/DZ2509A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DZ980119A 1997-06-02 1998-06-02 Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant. DZ2509A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97401212A EP0882736A1 (fr) 1997-06-02 1997-06-02 Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DZ2509A1 true DZ2509A1 (fr) 2003-01-25

Family

ID=8229769

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980119A DZ2509A1 (fr) 1997-06-02 1998-06-02 Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.

Country Status (38)

Country Link
US (1) US6586402B1 (fr)
EP (2) EP0882736A1 (fr)
JP (1) JP4346115B2 (fr)
KR (1) KR100582510B1 (fr)
CN (1) CN1134450C (fr)
AP (1) AP1195A (fr)
AR (1) AR011734A1 (fr)
AT (1) ATE204297T1 (fr)
AU (1) AU746132B2 (fr)
BR (1) BR9809910A (fr)
CA (1) CA2292846C (fr)
CO (1) CO4790174A1 (fr)
CZ (1) CZ299308B6 (fr)
DE (1) DE69801369T2 (fr)
DK (1) DK0984982T3 (fr)
DZ (1) DZ2509A1 (fr)
EE (1) EE03879B1 (fr)
ES (1) ES2166166T3 (fr)
HK (1) HK1029124A1 (fr)
HU (1) HUP0003592A3 (fr)
ID (1) ID24520A (fr)
IL (1) IL133210A0 (fr)
JO (1) JO2034B1 (fr)
MA (1) MA26502A1 (fr)
MY (1) MY122262A (fr)
NO (1) NO321786B1 (fr)
NZ (1) NZ501463A (fr)
OA (1) OA11305A (fr)
PE (1) PE84999A1 (fr)
PL (1) PL195474B1 (fr)
PT (1) PT984982E (fr)
RU (1) RU2212247C2 (fr)
SI (1) SI0984982T1 (fr)
TN (1) TNSN98075A1 (fr)
TR (1) TR199902997T2 (fr)
TW (1) TW479062B (fr)
WO (1) WO1998055505A1 (fr)
ZA (1) ZA983992B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
JP2004510795A (ja) * 2000-10-13 2004-04-08 モナッシュ・ユニバーシティ 胸腺の再生を操作することによる移植片受容の改善
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
DE102004033902A1 (de) * 2004-07-14 2006-02-16 Zentaris Gmbh Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
DK1968635T3 (en) 2005-12-14 2014-12-15 Ambrx Inc Compositions and Methods of, and uses of non-natural amino acids and polypeptides
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
EP2829877B1 (fr) * 2012-03-18 2020-01-22 Shiseido Company, Ltd. Appareil, système et procédé pour l'analyse d'un échantillon d'une maladie
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
CN114014913B (zh) * 2022-01-10 2022-03-29 浙江湃肽生物有限公司南京分公司 醋酸曲普瑞林的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
DE2424287A1 (de) * 1974-05-18 1975-12-04 Hoechst Ag Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
ES2108684T3 (es) * 1988-02-10 1998-01-01 Tap Pharmaceuticals Inc Analogo de la hormona de liberacion de la hormona luteinizante (lhrh).
EP0842946A1 (fr) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2292846A1 (fr) 1998-12-10
IL133210A0 (en) 2001-03-19
PT984982E (pt) 2002-02-28
HK1029124A1 (en) 2001-03-23
OA11305A (en) 2003-08-25
DK0984982T3 (da) 2001-11-12
AP1195A (en) 2003-08-18
EE03879B1 (et) 2002-10-15
CA2292846C (fr) 2009-12-08
SI0984982T1 (en) 2002-02-28
TNSN98075A1 (fr) 2005-03-15
US6586402B1 (en) 2003-07-01
KR100582510B1 (ko) 2006-05-23
AU746132B2 (en) 2002-04-18
HUP0003592A3 (en) 2001-05-28
PE84999A1 (es) 1999-09-15
NZ501463A (en) 2001-07-27
ATE204297T1 (de) 2001-09-15
PL195474B1 (pl) 2007-09-28
NO995891D0 (no) 1999-12-01
PL337235A1 (en) 2000-08-14
NO995891L (no) 2000-02-01
BR9809910A (pt) 2000-08-01
EP0984982B1 (fr) 2001-08-16
JP4346115B2 (ja) 2009-10-21
EP0882736A1 (fr) 1998-12-09
KR20010013286A (ko) 2001-02-26
CN1134450C (zh) 2004-01-14
AR011734A1 (es) 2000-08-30
CO4790174A1 (es) 1999-05-31
MA26502A1 (fr) 2004-12-20
DE69801369D1 (de) 2001-09-20
NO321786B1 (no) 2006-07-03
RU2212247C2 (ru) 2003-09-20
ZA983992B (en) 1998-11-20
DE69801369T2 (de) 2002-05-16
AU7654198A (en) 1998-12-21
JP2002502396A (ja) 2002-01-22
MY122262A (en) 2006-04-29
ID24520A (id) 2000-07-20
EP0984982A1 (fr) 2000-03-15
JO2034B1 (en) 1999-05-15
HUP0003592A2 (hu) 2001-02-28
CN1263535A (zh) 2000-08-16
ES2166166T3 (es) 2002-04-01
TR199902997T2 (xx) 2000-03-21
TW479062B (en) 2002-03-11
CZ432999A3 (cs) 2000-06-14
WO1998055505A1 (fr) 1998-12-10
EE9900546A (et) 2000-06-15
AP9901702A0 (en) 1999-12-31
CZ299308B6 (cs) 2008-06-11

Similar Documents

Publication Publication Date Title
DZ2509A1 (fr) Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2696094B1 (fr) Nouvelles compositions pharmaceutiques contenant des cyclosporines.
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
FR2783246B1 (fr) Derives d'azetidine, leur preparation et les medicaments les contenant
HUP0003349A3 (en) Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
MA26802A1 (fr) Derives de streptogramine, leur preparation et les compositions qui les contiennent.
BR9811582B1 (pt) compostos derivados de 4-oxo-3,5-di-hidro-4h-piridazino[4,5-b]indol-1-acetamid a, medicamento e composição farmacêutica contendo os mesmos.
FR2740453B1 (fr) Melanges peptidiques, leur preparation et compositions cosmetiques les contenant
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
PL334125A1 (en) Novel analogues of camphotecin, their application as drugs and pharmaceutic agents containing them
ATE241364T1 (de) Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
HU9802590D0 (en) Sulfonamid-substituted and condensed compounds containing 5-membred ring, their use as medicament and pharmaceutical compositions containing them
FR2763340B1 (fr) Produits stabilisants, compositions les contenant, et leur utilisation
MA26809A1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent.
MA26662A1 (fr) Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation
FR2768737B1 (fr) Derives de carboxamidothiazoles, leur preparation, les compositions pharmaceutiques en contenant
MA26527A1 (fr) Oligo-thiophenes servant comme des agents antimetastatiques, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2757515B1 (fr) Formes prodrogues et nouveaux analogues de la camptothecine, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant